Technical Analysis for CGEN - Compugen Ltd.

Grade Last Price % Change Price Change
grade A 4.23 3.12% 0.13
CGEN closed up 3.12 percent on Friday, September 13, 2019, on 1.57 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CGEN trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
BB Squeeze Started Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for CGEN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Compugen Ltd., a therapeutic product discovery company, engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates primarily in the United States, Europe, and Israel. It focuses on the therapeutic proteins and monoclonal antibodies to address unmet needs in the fields of immunology and oncology. The company's therapeutic proteins pipeline includes CGEN-15001, a novel protein for the treatment of autoimmune disorders; CGEN-15021, a novel fusion protein for the treatment of multiple sclerosis, rheumatoid arthritis, and other autoimmune diseases; CGEN-15091, a novel fusion protein for the treatment of multiple sclerosis and autoimmune diseases; CGEN-15031, a fusion protein candidate to treat multiple sclerosis; and CGEN-15051, a fusion protein candidate for the treatment of rheumatoid arthritis. Its monoclonal antibody therapy product candidates include CGEN-15001T, a membrane protein target for the treatment of cancer; CGEN-15022 membrane protein for the treatment of multiple cancers; CGEN-671, a novel drug target for the treatment of multiple epithelial tumors; and CGEN-928 drug target for the treatment of multiple myeloma. Compugen Ltd. was founded in 1993 and is headquartered in Tel Aviv, Israel.
Medicine Biopharmaceutical Cancer Medical Specialties Life Sciences Immunology Treatment Of Cancer Antibodies Cancers Autoimmune Diseases Multiple Sclerosis Rheumatoid Arthritis Antibody Multiple Myeloma Monoclonal Antibody Autoimmunity Autoimmune Disorders Compugen Treatment Of Multiple Sclerosis Antibody Therapy Fusion Protein
Is CGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.31
52 Week Low 2.0
Average Volume 233,059
200-Day Moving Average 3.4613
50-Day Moving Average 3.6256
20-Day Moving Average 3.9181
10-Day Moving Average 3.8992
Average True Range 0.2081
ADX 23.15
+DI 27.5971
-DI 14.1694
Chandelier Exit (Long, 3 ATRs ) 3.6757
Chandelier Exit (Short, 3 ATRs ) 4.0343
Upper Bollinger Band 4.192
Lower Bollinger Band 3.6442
Percent B (%b) 1.07
BandWidth 13.981266
MACD Line 0.1148
MACD Signal Line 0.0969
MACD Histogram 0.0179
Fundamentals Value
Market Cap 216.29 Million
Num Shares 51.1 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -6.31
Price-to-Sales 1330.24
Price-to-Book 3.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.58
Resistance 3 (R3) 4.56 4.43 4.52
Resistance 2 (R2) 4.43 4.34 4.44 4.50
Resistance 1 (R1) 4.33 4.29 4.38 4.35 4.48
Pivot Point 4.20 4.20 4.23 4.21 4.20
Support 1 (S1) 4.10 4.11 4.15 4.12 3.98
Support 2 (S2) 3.97 4.06 3.98 3.96
Support 3 (S3) 3.87 3.97 3.94
Support 4 (S4) 3.89